{
    "abstract": "We aimed at assessing the association between meconium-stained amniotic fluid (MSAF) and adverse maternal and neonatal outcomes in early-term versus late-term pregnancies.\nEarly-term pregnancies (37-39 weeks of gestation) presented with MSAF were compared with late-term (40-42 weeks of gestation) pregnancies with MSAF. The groups were compared with respect to background characteristics, maternal outcomes, and neonatal outcomes. The composite neonatal outcome was the primary outcome of the study, and secondary outcomes included maternal and neonatal outcomes.\nThe early-term group comprised 239 women, compared with 362 women in the late-term group. The primary outcome did not differ between groups. We found a higher prevalence of gestational diabetes (8.37 vs. 3%, \nIn term pregnancies complicated by MSAF, adverse neonatal and maternal delivery outcomes are equivalent, regardless of gestational age, and therefore, any term pregnancy complicated by MSAF should be considered high risk and managed appropriately.\n\u00b7 In term pregnancies complicated by MSAF, adverse neonatal and maternal delivery outcomes are equivalent, regardless of gestational age.. \u00b7 Any term pregnancy complicated by MSAF should be considered high risk and managed appropriately.. \u00b7 Deliveries presented with MSAF are typically considered to be high risk and require close fetal surveillance by a certified team with resuscitation skills.. \u00b7 Our study may help to reduce the need for a close fetal surveillance and delivery interventions if MSAF is not identified as a risk factor for adverse outcomes in late-term pregnancies..",
    "authors": [
        {
            "affiliation": "Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.",
            "firstname": "Anat",
            "initials": "A",
            "lastname": "Lavie"
        },
        {
            "affiliation": "The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.",
            "firstname": "Shira",
            "initials": "S",
            "lastname": "Fisch"
        },
        {
            "affiliation": "Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.\nDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.\nDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.",
            "firstname": "Lee",
            "initials": "L",
            "lastname": "Reicher"
        },
        {
            "affiliation": "Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.",
            "firstname": "Eyal",
            "initials": "E",
            "lastname": "Zohav"
        },
        {
            "affiliation": "Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.",
            "firstname": "Sharon",
            "initials": "S",
            "lastname": "Maslovitz"
        }
    ],
    "conclusions": "In term pregnancies complicated by MSAF, adverse neonatal and maternal delivery outcomes are equivalent, regardless of gestational age, and therefore, any term pregnancy complicated by MSAF should be considered high risk and managed appropriately.",
    "copyrights": "Thieme. All rights reserved.",
    "doi": "10.1055/a-2053-8018",
    "journal": "American journal of perinatology",
    "keywords": [],
    "methods": null,
    "publication_date": "2023-03-15",
    "pubmed_id": "36918162",
    "results": "The early-term group comprised 239 women, compared with 362 women in the late-term group. The primary outcome did not differ between groups. We found a higher prevalence of gestational diabetes (8.37 vs. 3%, ",
    "title": "Correlation of Meconium-Stained Amniotic Fluid and Adverse Pregnancy Outcomes between 37 to 39 and 40 to 42 Weeks of Gestational Age.",
    "xml": "<Element 'PubmedArticle' at 0x788504988180>"
}